LivaNova (NASDAQ:LIVN – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.47 per share for the quarter. LivaNova has set its FY 2024 guidance at 2.950-3.050 EPS and its FY24 guidance at $2.95-3.05 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.
LivaNova (NASDAQ:LIVN – Get Free Report) last released its earnings results on Wednesday, February 21st. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.10. The business had revenue of $310.10 million for the quarter, compared to the consensus estimate of $287.65 million. LivaNova had a net margin of 1.53% and a return on equity of 12.23%. The firm’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same period last year, the firm posted $0.81 earnings per share. On average, analysts expect LivaNova to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
LivaNova Stock Performance
LivaNova stock opened at $55.02 on Wednesday. The firm’s 50 day simple moving average is $53.77 and its 200-day simple moving average is $50.55. The company has a market cap of $2.97 billion, a P/E ratio of 171.94 and a beta of 0.89. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.95 and a quick ratio of 2.51. LivaNova has a fifty-two week low of $42.75 and a fifty-two week high of $59.86.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on LivaNova
LivaNova Company Profile
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Read More
- Five stocks we like better than LivaNova
- Investing in Commodities: What Are They? How to Invest in Them
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Investing In Automotive Stocks
- Lockheed Martin Stock Aims for a Fresh All-Time High
- The 3 Best Blue-Chip Stocks to Buy Now
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.